Skip to content
Search

Latest Stories

Volunteers delivering medicines is fraught with risks, says senior pharmacy solicitor

When a pharmacy owner has the misfortune to be on the receiving end of a compensation claim because of a dispensing error or some other alleged wrongdoing by an employed pharmacist, locum or another member of staff, the claim is quickly passed on to the owner’s professional indemnity insurer.

A question seldom asked is why a claim is made against the pharmacy owner who has not been negligent, and seldom against the individual pharmacist who made the error.


The answer is a doctrine known as vicarious liability.

Owners are seen as having deeper pockets and until about 15 years ago, individual pharmacists did not have their own professional indemnity cover.

This month, the Supreme Court handed down two important judgments on vicarious liability.

In the Morrisons case, an unhappy employee posted online the payroll data of all the supermarket company’s staff, 9,000 of whom claimed compensation for breach of their confidentiality.

The Supreme Court ruled that an employer is vicariously liable for the wrongful acts of an employee if those acts were closely connected with what he was authorised to do, and that those acts could fairly and properly be regarded as done while acting in the ordinary course of his employment.

The Court ruled that the perpetrator was not engaged in furthering Morrisons’ business, but was pursuing a personal vendetta that was not closely connected with his employment.

So, no vicarious liability.

Until 2005, only an employer could be held vicariously liable, so a pharmacy owner would not have been held vicariously liable for the negligence of a self-employed locum.

The law has developed since then.

In this month’s other Supreme Court case, Barclays Bank had engaged a doctor to carry out medical assessments on employees.

He sexually assaulted many of them.

The doctor had died and could not be sued, so victims claimed that Barclays was vicariously liable.

The legal test was whether the doctor was carrying on business on his own account or whether his relationship with Barclays was akin to that of employment.

The Court held that the doctor was in business on his own account as a medical practitioner, so the claims were rejected.

Employing volunteers for medicines delivery

These days, a court would say that the relationship between a pharmacy owner and a locum was akin to that of employment.

But what about the volunteers who are stepping forward to help deliver medicines during the Covid-19 crisis?

There are so many things that can go wrong, including delivering medicines to the wrong patient or disclosing patient information unintentionally or deliberately.

An injured or aggrieved patient may want to claim compensation and they will probably start with the pharmacy owner, not least because they will know the name of the pharmacy but may not know the name of the volunteer.

A court is likely to decide that delivering medicines was done in the ordinary course of the activities of the pharmacy.

The same applies to an accidental breach of confidentiality.

It is more difficult to decide if the relationship between a volunteer and a pharmacy owner is akin to employment.

If no payment is involved, that points away from vicarious liability.

On the other hand, volunteers are not acting on their own account.

My guess is that a court would say a pharmacy owner is not vicariously liable for the negligence of a volunteer who is not paid.

Pharmacy owners who have to pay compensation because they are vicariously liable can claim a financial contribution from a negligent employee or volunteer so it is wise to check that any volunteer has liability insurance through an organisation that has referred them.

David Reissner is chair of the Pharmacy Law & Ethics Association

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less